Lead Manager
Kempen & Co acted as Lead Manager in Merus’ USD 120 million Capital Increase on Nasdaq.
In the last twelve months, Kempen & Co has successfully completed a large number of transactions in its Life Sciences & Healthcare franchise. Recent transactions include: